CAPITAL & REGIONAL PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50 GBX | +0.60% |
|
0.00% | -13.19% |
| Apr. 24 | Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results | CI |
| Apr. 22 | Capital & Regional picks Gerry Murphy as non-exec director | AN |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 203.7 | 259.4 | 82.7 | 97.4 | 104.9 | 109.5 | 109.5 | - |
| Enterprise Value (EV) 1 | 666.2 | 596.3 | 427.8 | 282.7 | 235.8 | 259.4 | 262.1 | 263.3 |
| P/E ratio | -8.01 x | -1.54 x | - | -2.68 x | 8.61 x | - | - | - |
| Yield | 8.63% | 8.4% | - | - | 8.47% | 11.4% | 12% | 12.7% |
| Capitalization / Revenue | 3.92 x | 5.26 x | 2.43 x | 3.36 x | 4.46 x | 4.56 x | 4.03 x | 3.85 x |
| EV / Revenue | 12.8 x | 12.1 x | 12.5 x | 9.75 x | 10 x | 10.8 x | 9.64 x | 9.26 x |
| EV / EBITDA | 14.1 x | 13.2 x | 15.2 x | 12.8 x | 13.4 x | 14 x | 11.5 x | 11 x |
| EV / FCF | 47.6 x | 39.2 x | -38.5 x | 33.3 x | 14.3 x | 51.9 x | 262 x | 132 x |
| FCF Yield | 2.1% | 2.55% | -2.59% | 3.01% | 7% | 1.93% | 0.38% | 0.76% |
| Price to Book | 0.47 x | 0.69 x | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 72,619 | 103,764 | 111,759 | 165,362 | 169,122 | 219,001 | 219,001 | - |
| Reference price 2 | 2.805 | 2.500 | 0.7400 | 0.5890 | 0.6200 | 0.5000 | 0.5000 | 0.5000 |
| Announcement Date | 3/14/19 | 3/5/20 | 3/9/21 | 3/8/22 | 3/2/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 51.9 | 49.3 | 34.1 | 29 | 23.5 | 23.99 | 27.18 | 28.44 |
| EBITDA 1 | 47.2 | 45.3 | 28.2 | 22.1 | 17.6 | 18.55 | 22.75 | 23.85 |
| EBIT 1 | 46.9 | 44.8 | 25.5 | 21.6 | 17.3 | 20.3 | 24.3 | 25.25 |
| Operating Margin | 90.37% | 90.87% | 74.78% | 74.48% | 73.62% | 84.61% | 89.42% | 88.78% |
| Earnings before Tax (EBT) 1 | -25.6 | -121 | -203.6 | -23.3 | 5 | 14.5 | 19.9 | 20.5 |
| Net income 1 | -25.6 | -121 | -203.4 | -26.4 | 12.1 | 15.7 | 19.9 | 20.5 |
| Net margin | -49.33% | -245.44% | -596.48% | -91.03% | 51.49% | 65.44% | 73.23% | 72.08% |
| EPS | -0.3500 | -1.620 | - | -0.2200 | 0.0720 | - | - | - |
| Free Cash Flow 1 | 14 | 15.2 | -11.1 | 8.5 | 16.5 | 5 | 1 | 2 |
| FCF margin | 26.97% | 30.83% | -32.55% | 29.31% | 70.21% | 20.84% | 3.68% | 7.03% |
| FCF Conversion (EBITDA) | 29.66% | 33.55% | - | 38.46% | 93.75% | 26.95% | 4.4% | 8.39% |
| FCF Conversion (Net income) | - | - | - | - | 136.36% | 31.85% | 5.03% | 9.76% |
| Dividend per Share 2 | 0.2420 | 0.2100 | - | - | 0.0525 | 0.0568 | 0.0600 | 0.0635 |
| Announcement Date | 3/14/19 | 3/5/20 | 3/9/21 | 3/8/22 | 3/2/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 S1 | 2021 S2 | 2022 S1 | 2023 S1 |
|---|---|---|---|---|---|
| Net sales | - | - | 15.6 | - | - |
| EBITDA | - | - | - | - | - |
| EBIT | - | - | - | - | - |
| Operating Margin | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| EPS | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | 0.0250 | 0.0275 |
| Announcement Date | 9/4/20 | 9/9/21 | 3/8/22 | 8/11/22 | 8/10/23 |
1GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 463 | 337 | 345 | 185 | 131 | 150 | 153 | 154 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 9.799 x | 7.437 x | 12.24 x | 8.385 x | 7.438 x | 8.083 x | 6.706 x | 6.449 x |
| Free Cash Flow 1 | 14 | 15.2 | -11.1 | 8.5 | 16.5 | 5 | 1 | 2 |
| ROE (net income / shareholders' equity) | 7.04% | 6.78% | - | 4.83% | 5.93% | 5% | 5.8% | 5.9% |
| ROA (Net income/ Total Assets) | 3.09% | 2.94% | - | - | - | - | - | - |
| Assets 1 | -828.7 | -4,123 | - | - | - | - | - | - |
| Book Value Per Share | 6.000 | 3.610 | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 19.1 | 13.4 | 15.6 | 8.3 | 10.6 | 15 | 10 | 10 |
| Capex / Sales | 36.8% | 27.18% | 45.75% | 28.62% | 45.11% | 62.52% | 36.8% | 35.16% |
| Announcement Date | 3/14/19 | 3/5/20 | 3/9/21 | 3/8/22 | 3/2/23 | - | - | - |
1GBP in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5
GBP
Average target price
0.686
GBP
Spread / Average Target
+37.20%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.19% | 136M | |
| -0.20% | 46.38B | |
| -13.75% | 12.39B | |
| -22.69% | 11.06B | |
| -13.01% | 10.74B | |
| -5.43% | 7.45B | |
| -6.66% | 6.54B | |
| -8.23% | 5.8B | |
| -7.60% | 5.6B | |
| -7.00% | 4.67B |
- Stock Market
- Equities
- CAL Stock
- Financials Capital & Regional plc
